NEW YORK--(BUSINESS WIRE)--Fitch Ratings does not expect any rating implications from Target Corporation's (Target) announcement that it has signed a definitive agreement to sell its pharmacy and clinic businesses to CVS Health (CVS) for pretax proceeds of $1.9 billion. Target's long-term Issuer Default Rating (IDR) is 'A-' and short-term IDR is 'F2'. The Rating Outlook is Stable. A full list of ratings follows at the end of this release. Target expects to deploy the after-tax net proceeds of a